As a ubiquitin E3 ligase, HSV1 ICP0 preferentially targets the SUMO-modified TRIM19/PML isoforms, leading to their degradation [210], among its many roles in HSV1 lytic and latent infection [211]. Here, PML is linked to disease arising from reactivation of latent virus.